Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation
Bone Marrow Transplant
.
2022 Sep;57(9):1451-1454.
doi: 10.1038/s41409-022-01734-2.
Epub 2022 Jun 9.
Authors
Julia Meissner
1
,
Michael Schmitt
2
,
Mindaugas Andrulis
3
4
,
Leonille Schweizer
5
6
,
Sascha Dietrich
2
,
Bettina Alber
2
,
Inga Harting
7
,
Felix T Kurz
7
8
,
Uwe M Martens
9
,
Anthony D Ho
2
,
Carsten Müller-Tidow
2
,
Peter Dreger
2
Affiliations
1
Department of Medicine V, University of Heidelberg, Heidelberg, Germany. julia.meissner@med.uni-heidelberg.de.
2
Department of Medicine V, University of Heidelberg, Heidelberg, Germany.
3
Department of General Pathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
4
Institute of Pathology, Klinikum Ludwigshafen, Ludwigshafen, Germany.
5
Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
6
Institute of Neuropathology, Charité, Berlin, Germany.
7
Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany.
8
Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
9
Department of Hematology/Oncology, Clinics Heilbronn GmbH, Heilbronn, Germany.
PMID:
35680996
PMCID:
PMC9439947
DOI:
10.1038/s41409-022-01734-2
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Central Nervous System
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, T-Cell, Peripheral*